Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
3.900
-0.120 (-2.99%)
Dec 5, 2025, 4:00 PM EST - Market closed
Sensus Healthcare Revenue
Sensus Healthcare had revenue of $6.88M in the quarter ending September 30, 2025, a decrease of -22.12%. This brings the company's revenue in the last twelve months to $35.61M, down -13.80% year-over-year. In the year 2024, Sensus Healthcare had annual revenue of $41.81M with 71.31% growth.
Revenue (ttm)
$35.61M
Revenue Growth
-13.80%
P/S Ratio
1.79
Revenue / Employee
$659,426
Employees
54
Market Cap
64.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.81M | 17.40M | 71.31% |
| Dec 31, 2023 | 24.41M | -20.13M | -45.20% |
| Dec 31, 2022 | 44.53M | 17.49M | 64.68% |
| Dec 31, 2021 | 27.04M | 17.47M | 182.36% |
| Dec 31, 2020 | 9.58M | -17.69M | -64.87% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SRTS News
- 22 days ago - Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer - Business Wire
- 24 days ago - Sensus Healthcare Appoints Eric Sachetta to its Board of Directors - Business Wire
- 4 weeks ago - Sensus Healthcare, Inc. (SRTS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Sensus Healthcare Reports Third Quarter 2025 Financial Results - Business Wire
- 4 weeks ago - Sensus Healthcare Named to TIME's America's Growth Leaders of 2026 - Business Wire
- 4 weeks ago - CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer - Business Wire
- 5 weeks ago - Sensus Healthcare Announces the Passing of Director Bill McCall - Business Wire
- 6 weeks ago - Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6 - Business Wire